BRIEF published on 11/05/2024 at 03:35, 16 days 7 hours ago Savencia Cheese USA Voluntarily Recalls Select Cheeses Due to Listeria Risk Food Safety Recall Soft Cheeses Savencia Cheese Listeria
PRESS RELEASE published on 11/05/2024 at 03:30, 16 days 7 hours ago CORRECTION: Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses Savencia Cheese USA recalls soft ripened cheeses due to potential Listeria monocytogenes contamination. Consumers advised to check product labels and return affected items for a refund Recall Voluntary Savencia Cheese USA Listeria Monocytogenes Product Labels
BRIEF published on 11/02/2024 at 16:15, 18 days 18 hours ago Savencia Cheese USA Voluntarily Recalls Select Cheeses Due to Listeria Risk Health Risks Listeria Recall Soft Cheeses FDA Coordination Savencia Cheese USA
PRESS RELEASE published on 11/02/2024 at 16:10, 18 days 18 hours ago Savencia Cheese USA Announces Voluntary Recall of Select Soft Ripened Cheeses Savencia Cheese USA announces voluntary recall of select soft ripened cheeses due to potential Listeria monocytogenes contamination. Consumers advised to check product labels for identification Voluntary Recall Consumer Safety Savencia Cheese USA Listeria Monocytogenes Product Labels
BRIEF published on 10/24/2024 at 07:51, 28 days 3 hours ago Savencia performance at the end of September 2024 International Market Organic Growth Turnover Dairy Products Savencia
PRESS RELEASE published on 10/24/2024 at 07:46, 28 days 3 hours ago SAVENCIA: Activity at the end of September 2024 Savencia Fromage & Dairy Group reports 1.3% sales growth in September 2024 driven by Other Dairy Products and favorable structural effects. Commitment to quality and sustainability initiatives highlighted Sustainability Sales Growth Commitments Savencia Dairy Group
BRIEF published on 09/19/2024 at 19:05, 2 months 1 day ago Savencia announces its 2024 half-year financial results Finance Net Profit Turnover Half-yearly Results Savencia
PRESS RELEASE published on 09/19/2024 at 19:00, 2 months 1 day ago SAVENCIA: 2024 Half-yearly financial report SAVENCIA SA releases condensed interim consolidated financial statements as of June 30, 2024, showing positive growth in net sales and earnings. Detailed breakdown of income, assets, and equity included Balance Sheet Interim Financial Statements Income Statement June 30 2024 Savencia SA
PRESS RELEASE published on 05/23/2023 at 15:00, 1 year 5 months ago Alouette Debuts NEW Brie for Grilling Just in Time for Summer
Published on 11/21/2024 at 10:03, 51 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 54 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 54 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 19 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 29 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:30, 24 minutes ago MS Industrie AG publishes unaudited key figures for the first 3 quarters 2024
Published on 11/21/2024 at 10:04, 49 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 52 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 54 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 54 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 06:58, 3 hours 56 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 34 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 17 hours 9 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 17 hours 9 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 3 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
